Vol.44,Issue 6,December 2023

Radiotherapy and gynaecological cancers during the pandemic: the role of hematologic toxicity

Potential mechanism of Astragalus polysaccharide increasing chemosensitivity of cervical cancer HeLa cells to carboplatin by modulating the PI3K/Akt signaling pathway

Neoadjuvant chemotherapy followed by radical surgery versus primary surgery in stage IB2–IIB cervical adenocarcinoma: a retrospective study

Surgical site infection after cytoreductive surgery in patients with ovarian, fallopian tube and primary peritoneal cancer, is an independent predictor of poor overall survival via significant delays in adjuvant chemotherapy

Construction of a ferroptosis-related lncRNA signature for predicting prognosis, immune response and drug sensitivity in cervical squamous cell carcinoma and endocervical adenocarcinoma

Fulfilled but worn out: gynecologic oncologists experience high levels of compassion satisfaction and compassion fatigue

Study on the effect of TP chemotherapy regimen combined with Qinggong detoxification soup on the clinical efficacy of cervical cancer patients

Beyond bladder dysfunction: assessing the full impact of radical hysterectomy on cervical cancer patients

The expression and clinical significance of apolipoprotein C1 in cervix cancer

Disparities in the surgical treatment of loco-regional endometrial cancer

Diagnostic potential of conventional ultrasonography combined with elastography in assessing the properties of axillary lymph nodes in breast cancer

Based on the surveillance, epidemiology, and end results programme, to develop and validate nomograms for predicting overall survival and cancer-specific survival in geriatric patients with vulvar squamous cell carcinoma

Prognostic factors and clinical hallmarks of low grade serous ovarian carcinoma: a single center study

Comprehensive analysis of hypoxia-related gene signature in cervical cancer

Effects of Sufentanil on proliferation, migration and epithelial-mesenchymal transition of endometrial cancer

An analysis of deviation from the ESGO quality indicators for surgical treatment of cervical cancer in a large referral center in the Netherlands

RTKN2, a potential target of breast cancer (BCa), can promote the growth and migration of breast cancer cells

Comparison of the clinical efficacy of paclitaxel + carboplatin and paclitaxel + cisplatin on tumor markers and WHOQOL-BREF score on cervical cancer patients

CKS1B promotes the growth of ovarian cancer cells by regulating the expression of PD-L1

Comments on the definition of ovarian cancer stage IC2, related to fertility-sparing treatment